Qs-21 and il-12 as an adjuvant combination

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/39 (2006.01) A61K 39/102 (2006.01)

Patent

CA 2409406

Adjuvant compositions comprising an effective amount IL-12 and QS-21 are disclosed. Immunogenic, vaccine and pharmaceutical compositions comprising a mixture of antigen and an adjuvant composition comprising an effective amount of IL-12 and QS-21 are also disclosed. These compositions elicit functional cell-mediated and humoral immune responses against at least one antigen. Methods of using the disclosed compositions are also disclosed.

Cette invention se rapporte à des compositions d'adjuvants qui comprennent une quantité efficace d'IL-12 et de QS-21. Des compositions immunogènes, de vaccins et pharmaceutiques comprenant un mélange d'antigène et d'une composition d'adjuvant contenant une quantité efficace d'IL-12 et de QS-21 sont également décrites. Ces compositions déclenchent des réactions immunitaires humorales et à médiation cellulaire fonctionnelle contre au moins un antigène. Des procédés d'utilisation de ces compositions sont également décrits.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Qs-21 and il-12 as an adjuvant combination does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Qs-21 and il-12 as an adjuvant combination, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Qs-21 and il-12 as an adjuvant combination will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1951215

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.